Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique

Author:

Ismael NaliaORCID,van Wyk Stephanie,Tegally Houriiyah,Giandhari Jennifer,San James Emmanuel,Moir MonikaORCID,Pillay Sureshnee,Utpatel Christian,Singh LavanyaORCID,Naidoo Yeshnee,Ramphal UpasanaORCID,Mabunda Nédio,Abílio NuroORCID,Arnaldo Paulo,Xavier Joicymara,Amoako Daniel Gyamfi,Everatt JosieORCID,Ramphal Yajna,Maharaj ArishaORCID,de Araujo Leonardo,Anyaneji Ugochukwu J.,Tshiabuila Derek,Viegas SofiaORCID,Lessells Richard,Engelbrecht Susan,Gudo Eduardo,Jani IleshORCID,Niemann Stefan,Wilkinson EduanORCID,de Oliveira Túlio

Abstract

Mozambique reported the first case of coronavirus disease 2019 (COVID-19) in March 2020 and it has since spread to all provinces in the country. To investigate the introductions and spread of SARS-CoV-2 in Mozambique, 1 142 whole genome sequences sampled within Mozambique were phylogenetically analyzed against a globally representative set, reflecting the first 25 months of the epidemic. The epidemic in the country was marked by four waves of infection, the first associated with B.1 ancestral lineages, while the Beta, Delta, and Omicron Variants of Concern (VOCs) were responsible for most infections and deaths during the second, third, and fourth waves. Large-scale viral exchanges occurred during the latter three waves and were largely attributed to southern African origins. Not only did the country remain vulnerable to the introductions of new variants but these variants continued to evolve within the borders of the country. Due to the Mozambican health system already under constraint, and paucity of data in Mozambique, there is a need to continue to strengthen and support genomic surveillance in the country as VOCs and Variants of interests (VOIs) are often reported from the southern African region.

Funder

Rockefeller Foundation

Department of Science and Innovation, South Africa and South African Medical Research Council

Abbott Pandemic Defense Coalition

German Federal Ministry

World Health Organization

National Institute of Health USA

European and Developing Countries Clinical Trials Partnership

H3BioNet Africa

Centers for Disease Control and Prevention

Bill & Melinda Gates Foundation

Publisher

Public Library of Science (PLoS)

Reference40 articles.

1. GISAID: Global initiative on sharing all influenza data -from vision to reality;Y Shu;Euro Surveill,2017

2. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2);N Masood;Front Cell Infect Microbiol,2020

3. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach;AAT Naqvi;Biochim Biophys Acta Mol Basis Dis,2020

4. New variants of SARS-CoV-2;R Cantón;Rev Esp Quimioter,2021

5. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic;SP Otto;Curr Biol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3